Guizhou Sanli Pharmaceutical Co., Ltd. Class ASSE: 603439

Announcement on Implementation of Dividend Distribution for 2025

Jun 24, 2026 · Issued by Guizhou Sanli Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Guizhou Sanli Pharmaceutical Co., Ltd. Class A

Announcement on Progress in Drug Marketing Authorization TransferJun 9
Announcement on Resolutions of the 24th Meeting of the 4th Board of DirectorsMay 26
Announcement on Resolutions of the 2025 Annual General MeetingMay 21
Announcement on the Holding of 2026 Collective Reception Day Activities for Investors of Listed Companies in Guizhou Jurisdiction and Outline of the 2025 Annual Performance BriefingMay 13

All Guizhou Sanli Pharmaceutical Co., Ltd. Class A news releases